These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 389405)

  • 21. [Acute leukaemia in the course of Hodgkin's disease: report of two cases (author's transl)].
    Mitrou PS; Fischer M; Martin H
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1596-7. PubMed ID: 4526423
    [No Abstract]   [Full Text] [Related]  

  • 22. Leukemia following Hodgkin's disease.
    Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
    N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second malignancy in patients treated by Hodgkin's disease.
    Baccarani M; Bosi A; Papa G
    Cancer; 1980 Oct; 46(8):1735-40. PubMed ID: 6932997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute leukemia following prolonged cytotoxic agent therapy.
    Casciato DA; Scott JL
    Medicine (Baltimore); 1979 Jan; 58(1):32-47. PubMed ID: 105227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of acute nonlymphocytic leukemia in a prospective randomized study of treatment for Hodgkin's disease.
    Gomez GA; Friedman M; Reese P
    Am J Clin Oncol; 1983 Jun; 6(3):319-23. PubMed ID: 6342359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for second malignant neoplasms: report from the Late Effects Study Group.
    Meadows AT
    Bull Cancer; 1988; 75(1):125-30. PubMed ID: 3359054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
    Sargur M; Buckner CD; Appelbaum FR; Stewart P; Deeg HJ; Weiden PL; Sullivan KM; Fefer A; Thomas ED
    J Clin Oncol; 1987 May; 5(5):731-4. PubMed ID: 3553436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of second cancers in patients treated for Hodgkin's disease.
    Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
    J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease.
    Armitage JO; Dick FR; Goeken JA; Foucar MK; Gingrich RD
    Arch Intern Med; 1983 Mar; 143(3):445-50. PubMed ID: 6338848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin's disease terminating in a T-cell immunoblastic leukemia.
    Dick FR; Maca RD; Hankenson R
    Cancer; 1978 Sep; 42(3):1325-9. PubMed ID: 308839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of second cancers after treatment for Hodgkin's disease.
    Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
    N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of second tumors in patients with Hodgkin's disease (review of the literature and personal data)].
    Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP
    Vopr Onkol; 1987; 33(5):11-8. PubMed ID: 3590664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute leukemia complicating Hodgkin's disease : five new cases (author's transl)].
    Jouet JP; Huart JJ; Bauters F; Goudemand M
    Nouv Presse Med; 1979 Feb; 8(8):613-4. PubMed ID: 461179
    [No Abstract]   [Full Text] [Related]  

  • 36. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
    Devereux S; Selassie TG; Vaughan Hudson G; Vaughan Hudson B; Linch DC
    BMJ; 1990 Nov; 301(6760):1077-80. PubMed ID: 2249071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases.
    De Gramont A; Louvet C; Krulik M; Smadja N; Donadio D; Laporte JP; Brissaud P; Smith M; Delâge JM; Drolet Y
    Cancer; 1986 Aug; 58(3):630-4. PubMed ID: 3731020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute non-lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia: cytogenetic studies.
    Whang-Peng J; Knutsen T; O'Donnell JF; Brereton HD
    Cancer; 1979 Nov; 44(5):1592-600. PubMed ID: 498031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA; Dixon DO
    Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.